Transfer of high cost drugs to NICE risks fragmentation of care of rare diseases

BMJ. 2012 Aug 24:345:e5727. doi: 10.1136/bmj.e5727.
No abstract available

Publication types

  • Letter

MeSH terms

  • Drug Costs*
  • Humans
  • Quality Assurance, Health Care / organization & administration
  • Rare Diseases* / economics
  • Rare Diseases* / therapy
  • Risk Sharing, Financial / methods*
  • United Kingdom